Flibanserin: the future ally of female sexual desire?
At the meeting of the Society European sexual medicine held in Lyon, were presented the results of the trial of Flibanserin, the active ingredient, initially created as an antidepressant that has been raised, currently, as a drug to increase female sexual desire. An application for approval has already been presented in the U.S. and short, will be proposed in Europa.Lo study, led in Europe by Rossella Nappi, professor of gynecology at the University of Pavia, involved 5,000 women in Europe and American between 18 and 45 years. The
Flibanserin acts on the brain, and particularly on serotonin The dopamine and norepinephrine , some neurotransmitters involved in the first phase of sexual response and, according to the same Nappi, serves to "turn on the desire to feel less stress, energize the relationship with partner . It has the effect of inhibiting the super-ego, praising the instinctive part of yourself. "
The choice of an active substance that acts on brain centers of the female sexual response demonstrates the recognition that the desire of women born in the head. For this region had failed " pink pill", the consideration of women's Viagra, as it acted only in the genitals, improving blood circulation. The results of this study seem to seal the difference between man and woman in the subtle mechanisms that govern sexuality.
How, in fact, says Andrea Genazzani, a gynecologist at the University of Pisa, men have fewer problems with desire, is more common, however, that present difficulties in the mechanism of erection and also argues that "women, however, happen to suffer when they lose the emotional world of adolescence or typical of the stories still fresh and exciting .... "
To read the rest of the article , you can go on benessere4u.it .
0 comments:
Post a Comment